CLDX R&D to Revenue
Celldex Therapeutics Inc · R&D to Revenue
CLDX R&D to Revenue
Latest reported16340.00%period ending
CLDX FY R&D/Revenue (0.00% → 16340.00%)
Latest values, visible window
High-resolution chart · PNG
CLDX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 16,340% | |
| 2,329.7721% | |
| 1,714.5285% | |
| 3,489.9448% | |
| 1,221.4793% | |
| 546.4276% | |
| 1,194.2905% | |
| 696.6765% | |
| 754.6967% | |
| 1,513.7931% | |
| 1,827.938% | |
| 2,910.792% | |
| 1,639.5281% | |
| 423.1209% | |
| 350.1241% | |
| 59.09% | |
| 172.3913% | |
| 353.3923% | |
| 362.4543% | |
| 366.3767% | |
| 455.3673% | |
| 202.2833% | |
| 216.3073% | |
| 219.3727% | |
| 644.9834% | |
| 1,411.7138% | |
| 530.6235% | |
| 259.0909% | |
| 441.6667% | |
| 545.4545% | |
| 200% | |
| 124.2857% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |